Summary
This observational study investigates the genetic basis for observed differences in cardiovascular benefit from long-chain omega-3 fatty acid supplementation between Black and White individuals in large epidemiological cohorts. The authors hypothesise that ancestry-correlated variation in FADS genes—which regulate fatty acid metabolism—may account for heterogeneous cardiovascular risk factor responses to omega-3 supplementation across racial groups. By examining FADS genetic variation alongside cardiovascular outcomes, the work aims to elucidate whether genetic polymorphisms explain empirical population differences observed in randomised trials.
Regional applicability
Whilst conducted in the United States, the findings are relevant to United Kingdom nutrition science and clinical practice given the ethnically diverse UK population and ongoing interest in precision nutrition approaches. However, transferability depends on whether FADS allele frequencies and linkage disequilibrium patterns differ between US and UK ethnic groups, and on whether UK dietary omega-3 intake and supplementation patterns mirror those studied.
Key measures
FADS genetic variation, cardiovascular risk factors, response to long-chain omega-3 fatty acid supplementation stratified by self-reported race/ethnicity
Outcomes reported
The study aimed to confirm population heterogeneity in cardiovascular risk factors (CRFs) related to long-chain omega-3 fatty acid (LCN3FA) supplementation between Black and White individuals, and to explore whether FADS genetic variation explains observed differences in response.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.